Lucentis

Medicinal product

(Invented) name

Lucentis

Active substance (s)

Ranibizumabas

Strength

10 mg/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA04, Ranibizumab

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2007-01-22

Date of renewal

Documents

Lucentis mokomoji medziaga pacientams DME PDR.pdf

Lucentis mokomoji medziaga pacientams RVO.pdf

Lucentis mokomoji medziaga pacientams CNV.pdf

Lucentis mokomoji medziaga pacientams AMD.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled syringe	1 ml
Ranibizumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98387	84489	1084489	užpildytas švirkštas	0,165 ml N1		Receptinis	EU/1/06/374/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-01-22	Registruotas